Personalized and Precision Medicine 2022

This reprint, guest edited by Anne-Marie Caminade, gives an impressionist overview of the current state of the art about "Personalized and Precision Medicine". Twenty contributions illustrate the diversity of the topic, including new approaches about cancers, neurodegenerative diseases, in...

Full description

Saved in:
Bibliographic Details
Other Authors: Caminade, Anne-Marie (Editor)
Format: Electronic Book Chapter
Language:English
Published: Basel MDPI - Multidisciplinary Digital Publishing Institute 2023
Subjects:
AZA
n/a
Online Access:DOAB: download the publication
DOAB: description of the publication
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000naaaa2200000uu 4500
001 doab_20_500_12854_98923
005 20230405
003 oapen
006 m o d
007 cr|mn|---annan
008 20230405s2023 xx |||||o ||| 0|eng d
020 |a books978-3-0365-7044-0 
020 |a 9783036570457 
020 |a 9783036570440 
040 |a oapen  |c oapen 
024 7 |a 10.3390/books978-3-0365-7044-0  |c doi 
041 0 |a eng 
042 |a dc 
072 7 |a M  |2 bicssc 
100 1 |a Caminade, Anne-Marie  |4 edt 
700 1 |a Caminade, Anne-Marie  |4 oth 
245 1 0 |a Personalized and Precision Medicine 2022 
260 |a Basel  |b MDPI - Multidisciplinary Digital Publishing Institute  |c 2023 
300 |a 1 electronic resource (286 p.) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
506 0 |a Open Access  |2 star  |f Unrestricted online access 
520 |a This reprint, guest edited by Anne-Marie Caminade, gives an impressionist overview of the current state of the art about "Personalized and Precision Medicine". Twenty contributions illustrate the diversity of the topic, including new approaches about cancers, neurodegenerative diseases, infectious diseases, lungs obstruction, skeletal diseases, intestinal microbiomes, new tools such as ultra-high-frequency ultrasound or non-oncological radiotherapy, and a new class of drugs (dendrimers). This reprint is an illustration of the present and future impact of Personalized and Precision Medicine on all the therapeutic domains. 
540 |a Creative Commons  |f https://creativecommons.org/licenses/by/4.0/  |2 cc  |4 https://creativecommons.org/licenses/by/4.0/ 
546 |a English 
650 7 |a Medicine  |2 bicssc 
653 |a cancer treatment 
653 |a immune checkpoint blockade 
653 |a PD-(L)1 inhibitors 
653 |a interorganizational transaction 
653 |a combination therapy 
653 |a bacteremia 
653 |a carbapenemase 
653 |a carbapenem-resistant Enterobacteriaceae 
653 |a Klebsiella pneumoniae 
653 |a mortality 
653 |a risk factors 
653 |a bone-anchored maxillary protraction 
653 |a skeletal class III malocclusion 
653 |a 3D printing 
653 |a growth modification 
653 |a cancer 
653 |a mucormycosis 
653 |a COVID-19 
653 |a COVID-associated mucormycosis 
653 |a diabetes 
653 |a steroids 
653 |a immunosuppression 
653 |a dendrimers 
653 |a clinical trials 
653 |a phases 1, 2, and 3 
653 |a polylysine 
653 |a polyamidoamine 
653 |a TPMT genotype 
653 |a TPMT poor metabolizers 
653 |a TPMT intermediate metabolizers 
653 |a AZA 
653 |a hepatotoxicity 
653 |a cumulative incidence of hepatotoxicity 
653 |a pharmacogenomics 
653 |a autoimmune disease 
653 |a preemptive genotyping 
653 |a TPMI 
653 |a black elderberry 
653 |a polyphenols 
653 |a prebiotic 
653 |a microbiota 
653 |a heart rate variability 
653 |a autonomic nervous system 
653 |a sleep 
653 |a obstructive sleep apnea 
653 |a radiotherapy 
653 |a non-malignant disorders 
653 |a non-oncological radiotherapy 
653 |a electromyography 
653 |a kinematic 
653 |a kinetic 
653 |a low back pain 
653 |a lumbar belt 
653 |a sit-to-stand 
653 |a chronic obstructive pulmonary disease 
653 |a overlap syndrome 
653 |a vitamin D 
653 |a ultrasound 
653 |a ultra-high frequency 
653 |a musculoskeletal 
653 |a imaging 
653 |a urinary bladder neoplasms 
653 |a neoadjuvant therapy 
653 |a cystectomy 
653 |a clinical decision rules 
653 |a prognosis 
653 |a multiple sclerosis 
653 |a personalized medicine 
653 |a autoimmune 
653 |a comorbidities 
653 |a hallmarks of cancer 
653 |a differential interactome 
653 |a system biomarkers 
653 |a druggability 
653 |a personalized treatments 
653 |a total knee arthroplasty 
653 |a fast track rehabilitation 
653 |a inpatient rehabilitation 
653 |a postoperative rehabilitation 
653 |a patient reported outcome measures 
653 |a Huntington's disease 
653 |a psychosocial effects 
653 |a underserved region 
653 |a disease burden 
653 |a genetic counselling 
653 |a genetic testing 
653 |a complications 
653 |a low-molecular-weight heparin 
653 |a thromboembolism 
653 |a cerebral palsy 
653 |a muscle spasticity 
653 |a primary cell culture 
653 |a satellite cells 
653 |a skeletal muscle 
653 |a muscle 
653 |a skeletal 
653 |a humans 
653 |a epigenomics 
653 |a DNA methylation 
653 |a regulatory non-coding RNAs 
653 |a Alzheimer's disease 
653 |a logopenic variant primary progressive aphasia 
653 |a empathy 
653 |a n/a 
856 4 0 |a www.oapen.org  |u https://mdpi.com/books/pdfview/book/6976  |7 0  |z DOAB: download the publication 
856 4 0 |a www.oapen.org  |u https://directory.doabooks.org/handle/20.500.12854/98923  |7 0  |z DOAB: description of the publication